<DOC>
	<DOCNO>NCT02676310</DOCNO>
	<brief_summary>This safety , tolerability , pharmacokinetics study bimatoprost male patient androgenetic alopecia ( AGA ) .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Bimatoprost Men With Androgenetic Alopecia ( AGA )</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>Mild moderate male pattern baldness ( androgenic alopecia ) ongoing hair loss least 1 year History Paget 's disease , osteoporosis , bone malignancy History bone fracture within previous 12 month , except metatarsal , metacarpal , skull fracture Patient currently undergo radiation therapy anticipate undergo radiation therapy time study Drug alcohol abuse within 12 month HIV positive Received hair transplant scalp reduction Use hair weave , hair extension wigs within 3 month Application topical medication , minoxidil nonsteroidal antiinflammatory drug ( NSAIDs ) scalp within 4 week</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>